The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Tsefalen 500 mg film-coated tablets for dogs



Nextmune Italy S.r.l.VPA23440/001/001

Main Information

Trade NameTsefalen 500 mg film-coated tablets for dogs
Active SubstancesCefalexin
Dosage FormTablet
Licence HolderNextmune Italy S.r.l.
License Holder AddressVia Gian Battista Benzoni 50
Palazzo Pignano
CR
26020
Italy
Licence NumberVPA23440/001/001

Group Information

ATC CodeQJ01DB01 cefalexin
Therapeutic ClassAntibacterial
SpeciesDogs

Status

License statusAuthorised
Licence Issued09/11/2012
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *No document available
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back